Tatva Chintan Pharma Chem Limited share price
NSE: TATVA · ISIN INE0GK401011
Key numbers
- Market cap
- ₹ 4,195 Cr
- Current price
- ₹ 1,793.20
- 52-week high / low
- ₹ 1,838 / 982
- Stock P/E
- 81.3
- Book value
- ₹ 334.0
- Dividend yield
- 0.11%
- ROCE
- 7.1%
- ROE
- 5.5%
- Debt to equity
- 0.15
- Sales growth (3 yrs)
- 6.0%
- Profit growth (3 yrs)
- -2.6%
- 1-year return
- 66.5%
About Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and brominated flame retardants. The company serves automotive, consumer electronics, pharmaceutical, agrochemicals, paints and coatings, dyes, and personal care sectors. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 117 | 124 | 131 | 134 | 167 |
| Operating profit | 17 | 22 | 25 | 28 | 32 |
| Net profit | 7 | 10 | 15 | 10 | 16 |
| EPS (₹) | 2.84 | 4.24 | 6.49 | 4.41 | 6.83 |
Peers in Specialty Chemicals
Data for information only, not investment advice. Prices end of day.